A new path to hope
Brainsgate is a medical device company committed to developing a novel treatment modality, electrical SPG stimulation. This platform technology has been shown to increase blood flow to the brain and as a result has broad potential for treating central nervous system disorders. BrainsGate is currently focusing on improving the outcome of patients suffering from ischemic stroke, in a 24 hour window after onset of symptoms.
Deprecated: Methods with the same name as their class will not be constructors in a future version of PHP; news_class has a deprecated constructor in /home/brainsga/lib/news_class_v2.php on line 12
Deprecated: Function get_magic_quotes_gpc() is deprecated in /home/brainsga/lib/content_class.php on line 55
Deprecated: Function get_magic_quotes_gpc() is deprecated in /home/brainsga/lib/content_class.php on line 55
|
Focus: ISS
BrainsGate's product for the treatment of ischemic stroke and vascular dementia
read more |
|
Focus: Stroke
The leading cause of adult long-term disability and the third leading cause of death
read more |
|
July 15, 2014
ImpACT24 Interim Results
The Data Safety Monitoring Board (the "DSMB") for BrainsGate's study examined the interim results and deterimined the results support the continuation of the study > full story
January 1, 1970
> full story
|